Active Ingredient Semaglutide (Introductory GLP-1 Agonist) Total Strength per Vial Calibrated for 0.25mg and 0.5mg initial delivery Dose Classification Starter Phase & Early Titration Step 1 Primary Manufacturer Glenmark Pharmaceuticals Ltd Therapeutic Class Incretin Mimetic / Antidiabetic / Anti-Obesity Administration Route Subcutaneous Injection (Weekly calibrated dose) Supply Format 1 Multi-dose Vial / Pen System
Examining the Evidence The question of whether Ozempic directly causes blood clots requires careful examination of available clinical evidence and pharmacovigilance data
Mahaman YAR, Feng J, Huang F, Salissou MTM, Wang J, Liu R, Zhang B, Li H, Zhu F, Wang X (2022) Moringa Oleifera alleviates a burden and improves synaptic plasticity and cognitive impairments in APP/PS1 mice
Just give us a call, shoot us an e-mail, or use the form here
see this gallstones resource for patientfriendly explanations